52P RAS mutation status and mutation type as potential predictive biomarkers for thrombosis in metastatic colorectal cancer: A tertiary center 12-year cohort analysis
J.L. Mendes, S. Duarte Oliveira, Rosa M. Quinta‐Ferreira(University of Coimbra), J. Gramaça, R. Escaleira(Administração Regional de Saúde de Lisboa e Vale do Tejo), M. Seladas(Administração Regional de Saúde de Lisboa e Vale do Tejo), F. Verdasca(Administração Regional de Saúde de Lisboa e Vale do Tejo)
Cited by 0
Related Papers
Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms of the Rectum: A Case Report
|Case Reports in Oncology|2024|4
Male Breast Cancer in Portugal: A Descriptive Analysis of a 20-Year Cohort
|European Journal of Breast Health|2025|2
P-191 Ampullary neoplasms – how to treat in real-world practice? A retrospective study
|Annals of Oncology|2022|0
P-351 Colon cancer in young patients – real-world data from a single center review
|Annals of Oncology|2023|0
Neoadjuvant cisplatin-based chemotherapy (NAC) in Muscle-invasive bladder cancer (MIBC): Real-world data
|European Urology Open Science|2023|0